Literature DB >> 22314669

Natural history of the Sprint Fidelis lead: survival analysis from a large single-center study.

Leonidas Tzogias1, Diego Bellavia, Shivi Sharma, Thomas J Donohue, Mark H Schoenfeld.   

Abstract

PURPOSE: The purposes of our study were to: (1) determine lead failure rate in a large single-center cohort of Sprint Fidelis 6949 (Fidelis) leads, (2) define the risk of lead failure over time, (3) assess the impact of the Lead Integrity Alert (LIA) on lead failure presentation, and (4) identify independent predictors of Fidelis lead failure.
METHODS: All patients who underwent implantation of a Fidelis lead between September 2004 and July 2007 were included. Demographic, clinical, and device characteristics at the time of implant and prior to failure were collected and analyzed.
RESULTS: A total of 971 Fidelis leads (706 men, 265 women,mean age 68.4±12.8 years) were implanted. Over a mean follow-up of 46.3 months, there were 69 lead failures(7.1%). The 5-year lead survival rate was 90.3%. The risk of lead failure demonstrated a double-peaked pattern at 34 and 61 months. In multivariate analysis, there were no independent predictors of lead failure. Inappropriate shocks(IS) were the first sign of lead failure in 29 patients (42%).The incidence (32.6% vs. 65.2%, p=0.01) and number ofIS (2.8±7.2 vs. 11.3±18.7, p=0.01) were significantly lower in patients with LIA.
CONCLUSIONS: This study presents a single-center experience on the natural history of the Fidelis lead. In our experience, lead survival declines at a lower rate when compared to prior reports. The risk of lead failure demonstrated a double peaked pattern at approximately 3 and 5 years. No identified variable was predictive of lead failure. LIA was effective in reducing the incidence and number of IS.

Entities:  

Mesh:

Year:  2012        PMID: 22314669     DOI: 10.1007/s10840-011-9647-0

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  20 in total

1.  Sprint Fidelis 6949 high-voltage lead appears to be prone to early failure.

Authors:  Archana Rao; Jay Wright; Johan Waktare; Derick Todd
Journal:  Heart Rhythm       Date:  2007-09-18       Impact factor: 6.343

2.  Lead failures: dealing with even less perfect.

Authors:  Bruce L Wilkoff
Journal:  Heart Rhythm       Date:  2007-05-03       Impact factor: 6.343

3.  Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead.

Authors:  Melanie Maytin; Charles J Love; Avi Fischer; Roger G Carrillo; Juan D Garisto; Maria Grazia Bongiorni; Luca Segreti; Roy M John; Gregory F Michaud; Christine M Albert; Laurence M Epstein
Journal:  J Am Coll Cardiol       Date:  2010-07-02       Impact factor: 24.094

4.  Right-sided implantation and subpectoral position are predisposing factors for fracture of a 6.6 French ICD lead.

Authors:  Neil E Bernstein; Edmund T Karam; Anthony Aizer; Brian C Wong; Douglas S Holmes; Scott A Bernstein; Larry A Chinitz
Journal:  Pacing Clin Electrophysiol       Date:  2012-04-01       Impact factor: 1.976

5.  Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute.

Authors:  C L Byrd; B L Wilkoff; C J Love; T D Sellers; K T Turk; R Reeves; R Young; B Crevey; S P Kutalek; R Freedman; R Friedman; J Trantham; M Watts; J Schutzman; J Oren; J Wilson; F Gold; N E Fearnot; H J Van Zandt
Journal:  Pacing Clin Electrophysiol       Date:  1999-09       Impact factor: 1.976

6.  The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries.

Authors:  Sana M Al-Khatib; F Lee Lucas; James G Jollis; David J Malenka; David E Wennberg
Journal:  J Am Coll Cardiol       Date:  2005-09-23       Impact factor: 24.094

7.  Predictors of fracture risk of a small caliber implantable cardioverter defibrillator lead.

Authors:  Andrew C T Ha; Brian Z Vezi; Arieh Keren; Haitham Alanazi; Michael H Gollob; Martin S Green; Robert Lemery; Pablo B Nery; Emoke Posan; David H Birnie
Journal:  Pacing Clin Electrophysiol       Date:  2009-12-01       Impact factor: 1.976

8.  Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.

Authors:  Robert G Hauser; Linda M Kallinen; Adrian K Almquist; Charles C Gornick; William T Katsiyiannis
Journal:  Heart Rhythm       Date:  2007-04-10       Impact factor: 6.343

9.  Predictors of complications of endovascular chronic lead extractions from pacemakers and defibrillators: a single-operator experience.

Authors:  Sunil K Agarwal; Swapna Kamireddy; Jan Nemec; Andrew Voigt; Samir Saba
Journal:  J Cardiovasc Electrophysiol       Date:  2008-09-03

10.  Time-dependent risk of Fidelis lead failure.

Authors:  Brett A Faulknier; Darren M Traub; Mehmet K Aktas; Alian Aguila; Spencer Rosero; James P Daubert; Burr Hall; Abrar Shah; Sarah Taylor; Scott McNitt; Arthur J Moss; Wojciech Zareba; David T Huang
Journal:  Am J Cardiol       Date:  2010-01-01       Impact factor: 2.778

View more
  1 in total

Review 1.  Adverse events following implantable cardioverter defibrillator implantation: a systematic review.

Authors:  Rebecca Persson; Amy Earley; Ann C Garlitski; Ethan M Balk; Katrin Uhlig
Journal:  J Interv Card Electrophysiol       Date:  2014-06-20       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.